Trial Profile
An open-label, 8-week trial assessing safety and efficacy of calcipotriene and betamethasone dipropionate topical suspension in adolescents with scalp psoriasis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 14 Dec 2015 New trial record